Coapt, Chicago, announces it has licensed implantable technology from Purdue Research Foundation for use in Coapt’s Complete Control system that helps users move their prostheses intuitively.

The Complete Control system is a small device that helps move a user’s prosthesis by reading the body’s muscle impulses through sensors placed on the user’s skin inside the prosthetic arm. This technology is limited, however, because the sensors do not receive all of the amputee’s information.

The technology that Coapt has licensed from Purdue Research Foundation are implantable electrodes that help read these electrical signals more clearly from underneath the skin, explains a media release from Coapt.

“Our revolutionary control technologies allow amputees to regain their independence with a system that controls their prostheses better than ever before,” states Blair Lock, co-founder and CEO of Coapt, in the release. “Our exclusive licensing of Purdue’s implantable technology is a game-changer in prosthetics and orthotics.

“The group at Coapt has developed significant talent and resources, so they are the ideal partner to make this implantable technology available to those who need it,” adds Chad Pittman, Purdue Research Foundation Office of Technology Commercialization vice president, in the release. “With this license and their innovative expertise, they truly can change the lives of amputees.”

For more information, visit Coapt.

[Source(s): Coapt, PR Newswire]